UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Value of IgA anticardiolipin and anti-β2-glycoprotein I antibody testing in patients with pregnancy morbidity

Annals of the rheumatic diseases, 2003-06, Vol.62 (6), p.540-543

2003

Volltextzugriff (PDF)

POS0462 HYDROXYCHLOROQUINE REDUCES THE TITERS OF ANTI-DOMAIN 1 ANTIBODIES OVER TIME IN PATIENTS WITH PERSISTENTLY POSITIVE ANTIPHOSPHOLIPID ANTIBODIES: RESULTS FROM THE APS ACTION CLINICAL DATABASE AND REPOSITORY (“REGISTRY”)

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.484-485

2022

Volltextzugriff (PDF)

Prevalence and clinical correlations of antibodies against six β2-glycoprotein-I-related peptides in the antiphospholipid syndrome

Journal of clinical immunology, 2003-09, Vol.23 (5), p.377-383

2003

Volltextzugriff (PDF)

Prevalence and Clinical Correlations of Antibodies Against Six beta 2-Glycoprotein-I-Related Peptides in the Antiphospholipid Syndrome

Journal of clinical immunology, 2003-09, Vol.23 (5), p.377-383

2003

Volltextzugriff (PDF)

FRI0425 The Global Antiphospholipid Syndrome Score (GAPSS) Differentiates Between Transient Ischemic Attack and Stroke in Patients with Antiphospholipid Antibodies

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.581-581

2015

Volltextzugriff (PDF)

AB1071 Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS Action) Core Laboratory Validation Exercise: Comparison of Chemiluminescence Immunoassay (CIA) and Enzyme-Linked Immunosorbant Assay (ELISA)

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1258-1258

2015

Volltextzugriff (PDF)

AB0561 Needs-Assessment Survey for the Update of the Current Antiphospholipid Syndrome (APS) Classification Criteria

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1087-1087

2015

Volltextzugriff (PDF)

OP0223 Significance of IGG Phosphatidylserine-Dependent Antiprothrombin Antibody Testing for the Diagnosis of Antiphospholipid Syndrome: Results from the Initial and Validation International Multi-Centre Studies

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.155-156

2015

Volltextzugriff (PDF)

SAT0202 International Multi-Centre Study to Evaluate the Clinical Significance of Phosphatidylserine-Dependent Antiprothrombin Antibodies for the Diagnosis of Antiphospholipid Syndrome

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.662-663

2014

Volltextzugriff (PDF)

SAT0161 Fluvastatin treatment prevents the inflammatory/oxidative status linked to the clinical activity of the disease in systemic lupus erythematosus patients

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.526-526

2013

Volltextzugriff (PDF)

THU0184 Identification of biomarkers in SLE pregnancies using urinary proteomics

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.217-217

2013

Volltextzugriff (PDF)

SLE and antiphospholipid syndrome: 168. Dyslipidaemia, Hyperhomocysteinaemia and Antiphospholipid Antibodies as Risk Factors of Thrombotic Complications in Patients with Systemic Lupus Erythematosus

Rheumatology (Oxford, England), 2011-04, Vol.50 (Supplement 3), p.iii106-iii110

2011

Volltextzugriff (PDF)

Plasma Tumor Necrosis Factor α Levels and the –238 A Promoter Polymorphism in Patients with Antiphospholipid Syndrome

Thrombosis and haemostasis, 2001, Vol.85 (2), p.198-203

2001

Volltextzugriff (PDF)

Value of IgA anticardiolipin and anti-[beta]2-glycoprotein I antibody testing in patients with pregnancy morbidity

Annals of the rheumatic diseases, 2003-06, Vol.62 (6), p.540

2003

Volltextzugriff (PDF)

Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome

Rheumatology (Oxford, England), 1998-11, Vol.37 (11), p.1229

1998

Volltextzugriff (PDF)

Value of IgA anticardiolipin and anti-[β.sub.2]-glycoprotein I antibody testing in patients with pregnancy morbidity

Annals of the rheumatic diseases, 2003-06, Vol.62 (6), p.540

2003

Volltextzugriff (PDF)

Aids and Surgery

East and Central African journal of surgery, 2006-07, Vol.9 (2)

G. Morino, M. Baldan , E. D'Onofrio , A. Melotto, L. Bertolaccini

2006

Volltextzugriff (PDF)

IgG2 restriction of anti‐β2‐glycoprotein I as the basis for the association between IgG2 anticardiolipin antibodies and thrombosis in the antiphospholipid syndrome: Comment on the article by Sammaritano et al

Arthritis and rheumatism, 1998-08, Vol.41 (8), p.1513-1514

1998

Volltextzugriff (PDF)

The 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria

Arthritis & rheumatology (Hoboken, N.J.), 2023-10, Vol.75 (10), p.1687-1702

2023

Volltextzugriff (PDF)

FRI0606-HPR REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS, WHAT IS THE IMPACT ON ACCUMULATED DAMAGE?

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.908-909

2020

Volltextzugriff (PDF)

FRI0603-HPR COMORBIDITIES IN RHEUMATOID ARTHRITIS: UTILITY OF RACI SCORE (RHEUMATOID ARTHRITIS COMORBIDITY INDEX)

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.907-908

2020

Volltextzugriff (PDF)

AB0511 SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY SCORE (SLE- DAS) VALIDATION IN ARGENTINIAN PATIENTS

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1383-1383

2022

Volltextzugriff (PDF)

92P Predictors, surrogate and patient-reported outcomes in neoadjuvant immunotherapy for lung cancer: A single-center retrospective study

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S94-S95

2023

Volltextzugriff (PDF)

P1.14-01 Current Practices in the Management of Malignant Pericardial Effusions: A Survey Amongst Members of the European Society of Thoracic Surgeons

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S600-S600

2018

Volltextzugriff (PDF)

AB1145 EVALUATION OF THE HUMORAL IMMUNE RESPONSE SECONDARY TO VACCINATION AGAINST SARS-CoV2 IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.1689-1689

2022

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Value of IgA anticardiolipin and anti-β2-glycoprotein I antibody testing in patients with pregnancy morbidity

POS0462 HYDROXYCHLOROQUINE REDUCES THE TITERS OF ANTI-DOMAIN 1 ANTIBODIES OVER TIME IN PATIENTS WITH PERSISTENTLY POSITIVE ANTIPHOSPHOLIPID ANTIBODIES: RESULTS FROM THE APS ACTION CLINICAL DATABASE AND REPOSITORY (“REGISTRY”)

Prevalence and clinical correlations of antibodies against six β2-glycoprotein-I-related peptides in the antiphospholipid syndrome

Prevalence and Clinical Correlations of Antibodies Against Six beta 2-Glycoprotein-I-Related Peptides in the Antiphospholipid Syndrome

FRI0425 The Global Antiphospholipid Syndrome Score (GAPSS) Differentiates Between Transient Ischemic Attack and Stroke in Patients with Antiphospholipid Antibodies

AB1071 Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS Action) Core Laboratory Validation Exercise: Comparison of Chemiluminescence Immunoassay (CIA) and Enzyme-Linked Immunosorbant Assay (ELISA)

AB0561 Needs-Assessment Survey for the Update of the Current Antiphospholipid Syndrome (APS) Classification Criteria

OP0223 Significance of IGG Phosphatidylserine-Dependent Antiprothrombin Antibody Testing for the Diagnosis of Antiphospholipid Syndrome: Results from the Initial and Validation International Multi-Centre Studies

SAT0202 International Multi-Centre Study to Evaluate the Clinical Significance of Phosphatidylserine-Dependent Antiprothrombin Antibodies for the Diagnosis of Antiphospholipid Syndrome

SAT0161 Fluvastatin treatment prevents the inflammatory/oxidative status linked to the clinical activity of the disease in systemic lupus erythematosus patients

THU0184 Identification of biomarkers in SLE pregnancies using urinary proteomics

SLE and antiphospholipid syndrome: 168. Dyslipidaemia, Hyperhomocysteinaemia and Antiphospholipid Antibodies as Risk Factors of Thrombotic Complications in Patients with Systemic Lupus Erythematosus

Plasma Tumor Necrosis Factor α Levels and the –238 A Promoter Polymorphism in Patients with Antiphospholipid Syndrome

Value of IgA anticardiolipin and anti-[beta]2-glycoprotein I antibody testing in patients with pregnancy morbidity

Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome

Value of IgA anticardiolipin and anti-[β.sub.2]-glycoprotein I antibody testing in patients with pregnancy morbidity

Aids and Surgery

IgG2 restriction of anti‐β2‐glycoprotein I as the basis for the association between IgG2 anticardiolipin antibodies and thrombosis in the antiphospholipid syndrome: Comment on the article by Sammaritano et al

The 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria

FRI0606-HPR REMISSION IN SYSTEMIC LUPUS ERYTHEMATOSUS, WHAT IS THE IMPACT ON ACCUMULATED DAMAGE?

FRI0603-HPR COMORBIDITIES IN RHEUMATOID ARTHRITIS: UTILITY OF RACI SCORE (RHEUMATOID ARTHRITIS COMORBIDITY INDEX)

AB0511 SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY SCORE (SLE- DAS) VALIDATION IN ARGENTINIAN PATIENTS

92P Predictors, surrogate and patient-reported outcomes in neoadjuvant immunotherapy for lung cancer: A single-center retrospective study

P1.14-01 Current Practices in the Management of Malignant Pericardial Effusions: A Survey Amongst Members of the European Society of Thoracic Surgeons

AB1145 EVALUATION OF THE HUMORAL IMMUNE RESPONSE SECONDARY TO VACCINATION AGAINST SARS-CoV2 IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES

Aktive Filter

Suchergebnisse filtern